Floatz logo

Polycap

Ischemic Heart Disease

St. John's Research InstituteN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Ischemic Heart Disease cohort.

Asset / SponsorPhaseRating
Ranolazine
East Carolina University
Phase 4A
Acetylsalicylic Acid
Rajaie Cardiovascular Medical and Research Center
Phase 4BBB
ATENOLOL
Xintong Pharmacy Company
Phase 4BBB
Ranolazine
East Carolina University
Phase 4BBB
Nebido
Sheffield Teaching Hospitals NHS Foundation Trust
Phase 4BB

View all 35 →

Same molecule, other indications

Polycap is also rated in:

peripheral vascular diseaseDormant
D
Indicative ·
30 / 100
View asset →
type 2 diabetes mellitusDormant
D
Indicative ·
30 / 100
View asset →
ischemic strokeDormant
D
Indicative ·
28 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →